Varenicline Tartrate Tablet, Film Coated
Product Images NDC 68462-893
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Varenicline Tartrate (NDC 68462-893). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure1 (89b8956b Cf71 4791 8e55 598ff52656f3 02)
Logo (89b8956b Cf71 4791 8e55 598ff52656f3 03)
Dis (89b8956b Cf71 4791 8e55 598ff52656f3 04)
Starter Carton Pack (89b8956b Cf71 4791 8e55 598ff52656f3 05)
Starter Wallet Pack (89b8956b Cf71 4791 8e55 598ff52656f3 06)
0.5 mg 56 Bottles (89b8956b Cf71 4791 8e55 598ff52656f3 07)
1 mg- 56 Bottles Pack (89b8956b Cf71 4791 8e55 598ff52656f3 08)
Continuing Wallet Pack (89b8956b Cf71 4791 8e55 598ff52656f3 09)
Continuing Carton Pack (89b8956b Cf71 4791 8e55 598ff52656f3 10)
Image (89b8956b Cf71 4791 8e55 598ff52656f3 188 1)
Image (89b8956b Cf71 4791 8e55 598ff52656f3 192 1)
Figure 3 shows the continuous abstinence rate during the nontreatment follow-up period. The graph displays the abstinence rates for Vararicine wbiets and Placebo, with different dosage levels. The x-axis represents the weeks of nontreatment follow-up, while the y-axis shows the continuous abstinence rate. The graph also includes numerical values for each week of follow-up. Unfortunately, the rest of the text is not readable.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.